CC
DMTK

Cannell & Co’s DermTech, Inc. Common Stock DMTK Stock Holding History

Cannell & Co’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,876
Closed -$349K – 300
2021
Q3 		$349K Hold
10,876
– – 0.01% 247
2021
Q2 		$452K Buy
10,876
+1
+0% +$41 0.01% 228
2021
Q1 		$552K Buy
+10,875
New +$569K 0.02% 214

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Cannell & Co's DMTK Position: Q4 2021 in Review

Cannell & Co sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 10,876 shares — an estimated $349K sold.

Cannell & Co first reported a position in DMTK in Q1 2021 and held it in 3 quarters. The position peaked at $552K in Q1 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

  • Cannell & Co reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Cannell & Co sold 10,876 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $349K.
  • Cannell & Co first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Cannell & Co's DermTech, Inc. Common Stock position peaked at $552K in Q1 2021.
  • 143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Cannell & Co's 13F filing for Q4 2021, filed 9 Feb 2022.